Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Rubin

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Endocrine-Related Cancer|April 14, 2010
Molecular markers for novel therapies in neuroendocrine (carcinoid) tumorsJudith A Gilbert, Laura J Adhikari, Ricardo V Lloyd, et al.
Skeletal Radiology|October 6, 2005
Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problemMatthew R Callstrom, J William Charboneau, Matthew P Goetz, et al.
Investigational New Drugs|February 28, 2006
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumorsThierry Delaunoit, Patrick A Burch, Joel M Reid, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancerEvanthia Galanis, Stephanie K Carlson, Nathan R Foster, et al.
Cancer Research|November 5, 2002
Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpointsTony Reid, Eva Galanis, James Abbruzzese, et al.
Cancer Chemotherapy and Pharmacology|February 27, 2015
Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man studyHerbert I Hurwitz, David C Smith, Henry C Pitot, et al.
Journal of the American College of Cardiology|November 14, 2015
Early and Late Outcomes of Surgical Treatment in Carcinoid Heart DiseaseHeidi M Connolly, Hartzell V Schaff, Martin D Abel, et al.
Annals of Surgical Oncology|March 13, 2002
The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancerWilliam E Taylor, John H Donohue, Leonard L Gunderson, et al.
Clinical Colorectal Cancer|August 8, 2007
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248Steven R Alberts, George P Kim, Michelle R Mahoney, et al.
International Journal of Oncology|February 4, 2010
Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trialsAminah Jatoi, Nathan R Foster, James R Egner, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Endocrine-Related Cancer|April 14, 2010
Molecular markers for novel therapies in neuroendocrine (carcinoid) tumorsJudith A Gilbert, Laura J Adhikari, Ricardo V Lloyd, et al.
Skeletal Radiology|October 6, 2005
Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problemMatthew R Callstrom, J William Charboneau, Matthew P Goetz, et al.
Investigational New Drugs|February 28, 2006
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumorsThierry Delaunoit, Patrick A Burch, Joel M Reid, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancerEvanthia Galanis, Stephanie K Carlson, Nathan R Foster, et al.
Cancer Research|November 5, 2002
Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpointsTony Reid, Eva Galanis, James Abbruzzese, et al.
Cancer Chemotherapy and Pharmacology|February 27, 2015
Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man studyHerbert I Hurwitz, David C Smith, Henry C Pitot, et al.
Journal of the American College of Cardiology|November 14, 2015
Early and Late Outcomes of Surgical Treatment in Carcinoid Heart DiseaseHeidi M Connolly, Hartzell V Schaff, Martin D Abel, et al.
Annals of Surgical Oncology|March 13, 2002
The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancerWilliam E Taylor, John H Donohue, Leonard L Gunderson, et al.
Clinical Colorectal Cancer|August 8, 2007
Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248Steven R Alberts, George P Kim, Michelle R Mahoney, et al.
International Journal of Oncology|February 4, 2010
Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trialsAminah Jatoi, Nathan R Foster, James R Egner, et al.
Pageof 5